SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

BLCO

Bausch + Lomb Corporation
NYSEHealth Care

Latest close: 16.49 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 28, 2026Notice of sale · Form 144Ling Karen · Former Director · $75.7KOpen the filing ↗
  3. Aug 12, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record3424 flagged findings
Reported transactions (Form 4)59since Mar 1, 2023 · and 9 other holdings
Corporate events (8-K)30since Jul 20, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-04-29export control restrictionsrecentOpen filing ↗
    “…activity and sanctions against Russia, Belarus and specific areas of Ukraine have continued, the war has continued to affect…”
  • 2026-04-29capital return (buybacks/dividends)recentOpen filing ↗
    “…financing on reasonable terms or at all. We regularly evaluate market conditions, our liquidity profile and various financing…”
    +1 more passage from the same document
    • “…events of default. These affirmative and negative covenants include, among other things, and subject to certain qualifications…”
  • 2026-02-18export control restrictionsrecentOpen filing ↗
    “…(including Iran) and elsewhere. Broader geopolitical tensions remain high among the United States, Russia, China, Venezuela and…”
    +1 more passage from the same document
    • “…and cash flows, could be adversely impacted. Furthermore, if the sanctions and other retaliatory measures imposed by the global…”
  • 2026-02-18capital return (buybacks/dividends)recentOpen filing ↗
    “…financing on reasonable terms or at all. We regularly evaluate market conditions, our liquidity profile and various financing…”
    +1 more passage from the same document
    • “…and specified events of default. These affirmative and negative covenants include, among other things, and subject to certain…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 342)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

342 filings on record, the oldest from Jun 24, 21.

Listing the 25 most recent filings of the 342 on record.

8-Ks, explained

Structure14Governance19
  • Oct 13, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Aug 12, 26GovernanceA senior executive left or was appointed8-K/A 5.02 ↗
  • Aug 6, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jan 2, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Dec 22, 25GovernanceA senior executive left or was appointed8-K/A 5.02 ↗
  • Dec 17, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Aug 18, 25StructureA material agreement was terminated+3 more in the same filing8-K 1.02 ↗
  • Jul 23, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jun 27, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Nov 1, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2023 – 2024show all 3hide
    • May 29, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Feb 28, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Nov 7, 23GovernanceA senior executive left or was appointed8-K/A 5.02 ↗
  • Sep 29, 23StructureTook on a new financial obligation+3 more in the same filing8-K 2.03 ↗

9 older filings not shown · The record reaches back to May 10, 22.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Sale intention announced

On Sep 28, Ling Karen filed notice of intent to sell up to $76K.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

No sale of theirs is on record yet in Form 4; the 90-day window is still open.

View notice (Form 144) ↗+4 more recent notices · 3 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 10, 26Sell$888KFrederick MunschSVP, Controller and CAO↗
  • Aug 7, 26Sell$100KESCHENBACH ANDREW C. VON↗
  • Aug 6, 26Sell$206KESCHENBACH ANDREW C. VON↗
  • Mar 6, 26Buy$252KBRENT L SAUNDERSCEO and Chairman of the Board↗
  • Mar 6, 26Buy$69KSam EldessoukyEVP and CFO↗
  • Mar 6, 26Buy$250KA Robert D BaileyEVP & Chief Legal Officer↗
Stock compensation, tax and giftsshow the 34 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 12, 26Compensationamount n/aRobert J Chersi↗
  • Aug 12, 26Compensationamount n/aLAURENCE E PAUL↗
  • Aug 12, 26Compensationamount n/aBarbara Trebbi↗
  • Aug 5, 26Tax$71KBRENT L SAUNDERSChairman of the Board and CEO↗
  • Aug 5, 26Compensationamount n/aBRENT L SAUNDERSChairman of the Board and CEO↗
  • Aug 5, 26Compensationamount n/aA Robert D BaileyEVP & Chief Legal Officer↗
  • Aug 5, 26Compensationamount n/aLuc BonnefoyPresident, Surgical↗
  • Aug 5, 26Compensationamount n/aSam EldessoukyEVP and CFO↗
  • Aug 5, 26Compensationamount n/aYehia HashadEVP of R&D and CMO↗
  • Aug 5, 26Compensationamount n/aFrederick MunschSVP, Controller and CAO↗
  • Aug 5, 26Compensationamount n/aAndrew J. StewartPresident, GPIC↗
  • Jun 12, 26Tax$15KLuc BonnefoyPresident, Surgical↗
  • May 26, 26Compensation$250KEduardo Alfonso↗
  • May 26, 26Compensation$250KNathalie D. Bernier↗
  • May 26, 26Compensation$250KSTEVEN H COLLIS↗
  • May 26, 26Compensation$250KSARAH B KAVANAGH↗
  • May 26, 26Compensation$250KKaren Ling↗
  • May 26, 26Compensation$250KJohn Paulson↗
  • May 26, 26Compensation$250KRUSSEL C ROBERTSON↗
  • May 26, 26Compensation$250KThomas W. Ross Sr.↗
  • May 26, 26Compensation$250KESCHENBACH ANDREW C. VON↗
  • May 22, 26Tax$46KBRENT L SAUNDERSChairman of the Board and CEO↗
  • May 5, 26Tax$192KLuc BonnefoyPresident, Surgical↗
  • May 5, 26Tax$139KFrederick MunschSVP, Controller and CAO↗
  • May 5, 26Tax$219KYehia HashadEVP of R&D and CMO↗
  • May 5, 26Tax$1.0MSam EldessoukyEVP and CFO↗
  • Apr 30, 26Compensation$22KEduardo Alfonso↗
  • Apr 30, 26Compensation$22KSTEVEN H COLLIS↗
  • Apr 30, 26Compensation$22KJohn Paulson↗
  • Apr 30, 26Compensation$26KRUSSEL C ROBERTSON↗
  • Apr 24, 26Tax$250KA Robert D BaileyEVP & Chief Legal Officer↗
  • Apr 24, 26Tax$67KAndrew J. StewartPresident, GPIC↗
  • Mar 6, 26Compensationamount n/aBRENT L SAUNDERSCEO and Chairman of the Board↗
  • Mar 6, 26Compensationamount n/aSam EldessoukyEVP and CFO↗

The full record holds 212 transactions and goes back to Dec 30, 22.

Its sector and its market

Bausch + Lomb Corporation among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Bausch + Lomb Corporation, the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Bausch + Lomb Corporation in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
342 documents on file, from Jun 24, 2021 to Oct 13, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Bausch + Lomb Corporation (BLCO): stock price history, insider trades and SEC filings — HornScout